Suzhou Medsys Tech Co Ltd

Suzhou Medsys Tech Co Ltd

603990 · SHG · Healthcare / Health Information Services

22.95CNY-1.91 (-7.68%)

Price History

Full chart

Market Stats

Previous Close24.86
Open24.95
Day Range22.37 – 25.22
52-Week Range13.74 – 25.03
Volume55.01M
Market Cap5.90B
P/E (TTM)322.33
Forward P/E0.00
EPS0.06
Dividend Yield0.00%
Beta0.53
50-Day Avg20.65
200-Day Avg17.77

About

Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive auxiliary diagnosis clinical information system that mines and scientifically analyzes for ICU patients' treatment data with medical information, such as patients' treatment information, inspection information, nursing information, and doctor's advice data. In addition, it offers DoCare operative medical behavior management system that establishes the intelligent management system for the operation resources and personnel behavior; and DoCare emergency clinical information system for management of emergency clinical, including pre-hospital first aid, pre-examination and triage, emergency rescue, emergency under observation, emergency operating room, emergency ICU, and patient outcome. Further, the company provides DoCare pre-hospital first aid clinical information system that provides a unified service platform, which has digital information for emergency command center, emergency doctors, emergency nurses, visiting medical personnel, and patients. Additionally, it offers smart OT, ICU, and emergency solutions; and smart specialty solutions, such as laminar airflow room, clinical pathway, and mobile nursing information systems, as well as central sterile supply department management systems. The company was founded in 2005 and is based in Suzhou, China.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Weng Kang
  • Employees632
  • HeadquartersNo. 222 Guijia Lane, Suzhou, China, 215021, China
  • Websitehttps://www.medicalsystem.com.cn

Leadership

  • Mr. Weng KangVice Chairman & GM · b. 1968
  • Mr. Hao MeiFinancial Director · b. 1992
  • Mr. Meng Hao LiDeputy GM & Secretary of the Board of Directors · b. 1993
  • Mr. Di WuDeputy General Manager · b. 1968
  • Fengying LiuAccounting Supervisor

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue62.27M101.33M142.79M180.47M201.87M240.64M268.68M284.28M333.12M308.08M353.85M305.51M618.14M464.07M299.60M
Growth (%)-+62.71%+40.92%+26.39%+11.86%+19.21%+11.65%+5.80%+17.18%-7.52%+14.86%-13.66%+102.33%-24.93%-35.44%
Cost of Revenue18.05M31.17M42.93M61.82M61.09M75.01M70.62M72.59M93.03M85.37M106.86M90.05M505.32M412.90M140.26M
Gross Profit44.22M70.16M99.86M118.65M140.78M165.64M198.07M211.69M240.08M222.71M246.99M215.46M112.82M51.17M159.34M
Gross Margin71.02%69.24%69.94%65.74%69.74%68.83%73.72%74.46%72.07%72.29%69.80%70.52%18.25%11.03%53.18%
Operating Expense48.01M63.86M82.02M100.10M113.90M141.53M145.18M151.21M186.16M173.99M195.60M171.40M374.77M304.43M142.52M
Operating Income-3.78M6.29M17.84M18.55M26.88M24.11M52.89M60.47M53.93M48.72M51.39M44.06M-261.95M-253.26M16.82M
Operating Margin-6.08%6.21%12.50%10.28%13.31%10.02%19.68%21.27%16.19%15.81%14.52%14.42%-42.38%-54.57%5.61%
EBITDA-340.85K10.27M18.59M27.51M50.04M57.13M67.96M76.22M73.33M70.10M71.78M61.79M-187.07M-124.96M48.85M
EBITDA Margin-0.55%10.13%13.02%15.24%24.79%23.74%25.30%26.81%22.01%22.75%20.29%20.22%-30.26%-26.93%16.30%
Net Income1.61M14.00M31.09M39.25M38.96M45.21M51.11M55.48M46.89M35.44M41.95M33.56M-269.42M-279.47M39.16M
Net Income Margin2.59%13.82%21.77%21.75%19.30%18.79%19.02%19.52%14.08%11.50%11.86%10.99%-43.59%-60.22%13.07%
R&D4.70M9.47M10.56M14.47M20.06M35.23M47.83M57.25M57.69M43.03M48.00M47.41M50.04M51.18M28.60M
R&D as % of Total Revenue7.54%9.34%7.40%8.02%9.93%14.64%17.80%20.14%17.32%13.97%13.57%15.52%8.10%11.03%9.55%
Interest Expense400.38K1.38M1.59M1.58M1.75M2.18M1.27M3.71M5.46M6.90M6.92M4.11M48.77M72.23M13.12M
Interest Expense % of Total Revenue0.64%1.36%1.12%0.87%0.87%0.91%0.47%1.31%1.64%2.24%1.96%1.35%7.89%15.56%4.38%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets85.72M141.25M195.25M278.84M435.34M690.34M626.50M717.21M760.27M1.52B1.31B1.63B3.92B3.16B1.25B
Total Liabilities66.81M63.90M86.82M131.16M248.70M295.37M192.72M244.06M253.08M280.22M215.86M270.78M2.82B2.36B403.48M
Total Equity18.91M77.35M108.43M147.68M186.63M394.97M433.79M472.36M498.77M1.23B1.09B1.36B1.10B799.63M834.93M
Cash15.94M61.07M71.81M85.53M115.50M287.78M80.29M168.60M149.86M906.71M320.13M883.34M478.23M119.34M293.97M
Total Debt12.60M23.00M23.00M59.88M137.44M146.91M70.00M103.75M129.90M135.00M80.63M163.18M1.33B363.30M275.98M
Net Debt-3.34M-38.07M-48.81M-25.64M21.94M-140.87M-10.29M-64.85M-19.96M-771.71M-239.50M-720.16M849.16M243.96M-17.99M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.11M10.83M32.84M40.82M37.54M32.56M-6.16M48.67M22.04M100.48M36.04M50.51M-316.65M-11.39M65.41M
Investing Cash Flow-12.72M-2.36M-22.01M-62.57M-79.94M-28.01M-128.40M30.71M-37.90M-23.63M-467.24M205.32M-862.53M-145.12M247.62M
Financing Cash Flow22.76M36.68M-2.23M33.77M71.77M171.27M-73.11M8.62M-4.32M680.55M-154.24M307.42M710.16M-156.63M-134.97M
Capital Expenditure1.73M2.37M21.03M62.59M79.94M28.01M40.11M16.62M12.89M8.88M40.99M24.58M599.84M252.29M68.58M
Free Cash Flow-4.83M8.46M11.81M-21.77M-42.40M4.55M-46.26M32.05M9.15M91.60M-4.95M25.93M-916.49M-263.69M-3.17M
Dividends Paid264.71K4.15M1.62M2.06M5.10M6.62M17.37M18.71M16.70M14.22M10.77M3.58M17.57M26.33M10.22M
FCF to OCF155.56%78.14%35.97%-53.33%-112.96%13.97%751.11%65.85%41.51%91.17%-13.74%51.34%289.43%2314.56%-4.85%
Dividend Paid to FCF-5.48%48.98%13.74%-9.48%-12.04%145.50%-37.55%58.39%182.58%15.53%-217.43%13.82%-1.92%-9.98%-321.99%

Earnings

Report DateApr 28, 2017Aug 17, 2017Oct 27, 2017Mar 31, 2018Apr 29, 2018Aug 7, 2018Oct 27, 2018Mar 31, 2019Apr 27, 2019Sep 1, 2019Oct 31, 2019Apr 24, 2020Aug 7, 2020Oct 29, 2020Dec 31, 2020Apr 16, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate------------------------
EPS Actual-0.020.090.080.12-0.030.090.000.23-0.020.050.020.190.060.040.130.040.04-0.010.100.030.04-0.010.06-0.04
Surprise------------------------
TimingPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-market-Pre-market--------

Key Statistics & Ratios

Market Cap5.90B
Enterprise Value5.64B
Trailing P/E322.33
Forward P/E0.00
Price / Sales20.40
Price / Book7.01
EPS0.06
Book Value2.79
Revenue (TTM)289.44M
Gross Profit (TTM)169.99M
EBITDA25.53M
Profit Margin6.03%
Operating Margin5.89%
Return on Equity2.27%
Return on Assets0.69%
Shares Outstanding305.25M
Shares Float233.02M
Beta0.53
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
0.04Jul 1, 2021
20201×
0.08Jul 3, 2020
20191×
0.10May 21, 2019
20181×
0.06May 23, 2018
20171×
0.06May 31, 2017

Stock Splits

  • Jul 7, 202313:10
  • Jun 30, 202213:10
  • Jul 3, 202013:10
  • May 21, 20197:5